Akèy › Timè stromal gastro-intestinal
Etid klinik pou Timè stromal gastro-intestinal ap rekrite nan Etazini
19 etid pou Timè stromal gastro-intestinal ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Miami, FL8 etid
- Boston, MA7 etid
- Philadelphia, PA6 etid
- Houston, TX6 etid
- New York City, NY6 etid
- San Diego, CA5 etid
- Nashville, TN5 etid
- Portland, OR5 etid
- Omaha, NE5 etid
- Dallas, TX4 etid
- Durham, NC4 etid
- Akron, OH4 etid
- Rochester, MN4 etid
- Cleveland, OH4 etid
- Chicago, IL4 etid
- Jacksonville, FL4 etid
- Ann Arbor, MI4 etid
- Seattle, WA4 etid
- Los Angeles, CA4 etid
- Washington, DC4 etid
- Birmingham, AL3 etid
- Cedar Rapids, IA3 etid
- Salt Lake City, UT3 etid
- Tampa, FL3 etid
- Aurora, CO3 etid
- St. Louis, MO3 etid
- San Francisco, CA3 etid
- Santa Monica, CA3 etid
- Baltimore, MD3 etid
- Columbus, OH3 etid
Pa eta
- Alabama3 etid
- Arizona4 etid
- Colorado5 etid
- Connecticut4 etid
- Florid11 etid
- Illinois6 etid
- Iowa4 etid
- Kalifòni11 etid
- Kansas3 etid
- Maryland6 etid
- Massachusetts9 etid
- Michigan7 etid
- Minnesota6 etid
- Missouri5 etid
- Nebraska5 etid
- New York8 etid
- North Carolina6 etid
- Ohio10 etid
- Oregon5 etid
- Pennsylvania6 etid
- Tennessee7 etid
- Texas7 etid
- Utah3 etid
- Washington4 etid
- Wisconsin4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
Ap rekriteEtid obsèvasyon
Laj 6 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04557969A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06760819DESTINY-PANTUMOUR04
Ap rekriteEtid obsèvasyon
Laj 18 a 130 · Tout sèks · Mizajou Sep 25, 2026 · NCT07124000A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07218926A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07585266Imatinib TDM in GIST
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT05493215KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT07406633A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Ap rekriteFaz 2
Laj 8 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05503797A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2026 · NCT05957367LRG GIST Patient Registry
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 13, 2026 · NCT07697248Integrated Cancer Repository for Cancer Research
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jun 16, 2026 · NCT05208047Preoperative Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal Tumor
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT07171203PH 2 Pemigatinib in SDH-deficient GIST
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT07434843A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Feb 5, 2026 · NCT06630234A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Feb 5, 2026 · NCT06655246Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT01048281A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2025 · NCT06805825ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT05366816Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.